Assessing Lifetime CVD Risks
Differences in risk-factor burden appear to translate into marked differences in lifetime risk of...
Read More
cvd
Surrogate Use in Diabetes: Compromising Care?
A recent analysis published in BMJ finds that the widespread use of surrogate endpoints in...
Read More
Protecting Against CVD in Type 2 Diabetes
Clinicians should take an active role in helping their patients with type 2 diabetes protect...
Read More
Coffee-Cardiovascular Disease Link Discounted in Women
For years, physicians have recommended that patients with cardiovascular disease (CVD) avoid...
Read More
Reducing Cardiovascular Medication Errors
In-hospital medication errors contribute significantly to the estimated 44,000 to 98,000 deaths...
Read More
Reducing the Burden of Peripheral Arterial Disease
Peripheral arterial disease (PAD) affects an estimated 8 to 10 million Americans, a number that is...
Read More
Helpful Guidelines for Heart Health in Diabetes
This Physician’s Weekly feature covering guidelines for heart health in diabetes was...
Read More
Early Observations From Look AHEAD
Type 2 diabetes continues to adversely impact life expectancy, quality of life, and medical costs....
Read MoreInterpreting Data on Intensive Glucose Control
New data shed light on whether or not patients with type 2 diabetes should undergo intensive glucose control to reduce their risk of developing heart disease.
Read More
Establishing Clear Criteria for Metabolic Syndrome
Metabolic syndrome is characterized by interrelated risk factors for cardiovascular disease (CVD)...
Read More
American College of Cardiology 2010 Scientific Sessions
The American College of Cardiology (ACC) held its 2010 annual scientific sessions from March 14 to...
Read More- 1
- 2